Home  >  Products  >  WT1 (Wilms tumor 1) Blocking Peptide (the N terminal of WT1)(100ug)
WT1 (Wilms tumor 1) Blocking Peptide (the N terminal of WT1)(100ug)

WT1 (Wilms tumor 1) Blocking Peptide (the N terminal of WT1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-WT1 Antibody (ARP37988_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAPP45795
Size: 100ug
Weight: 54kDa
Gene: 7490
Format: Lyophilized powder
Target: WT1 is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms.
Alternative names: AWT1; GUD; WAGR; WIT-2; WT33
See Full Product Listings >